APA (7th ed.) Citation

Goodridge, J. P., Mahmood, S., Zhu, H., Gaidarova, S., Blum, R., Bjordahl, R., . . . Valamehr, B. (2019). FT596: Translation of First-of-Kind Multi-Antigen Targeted Off-the-Shelf CAR-NK Cell with Engineered Persistence for the Treatment of B Cell Malignancies. Blood, 134(Supplement_1), 301. https://doi.org/10.1182/blood-2019-129319

Chicago Style (17th ed.) Citation

Goodridge, Jode P., et al. "FT596: Translation of First-of-Kind Multi-Antigen Targeted Off-the-Shelf CAR-NK Cell with Engineered Persistence for the Treatment of B Cell Malignancies." Blood 134, no. Supplement_1 (2019): 301. https://doi.org/10.1182/blood-2019-129319.

MLA (9th ed.) Citation

Goodridge, Jode P., et al. "FT596: Translation of First-of-Kind Multi-Antigen Targeted Off-the-Shelf CAR-NK Cell with Engineered Persistence for the Treatment of B Cell Malignancies." Blood, vol. 134, no. Supplement_1, 2019, p. 301, https://doi.org/10.1182/blood-2019-129319.